Histological severity and hepatic outcomes in patients with metabolic dysfunction-associated steatotic liver disease and discrepant FIB-4 and liver stiffness measurement
Background/Aims Current guidelines recommend a 2-step approach for identifying advanced fibrosis in metabolic dysfunction-associated steatotic liver disease (MASLD), using Fibrosis-4 index (FIB-4) followed by liver stiffness measurement (LSM) via vibration-controlled transient elastography (VCTE). H...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Korean Association for the Study of the Liver
2026-01-01
|
| Serier: | Clinical and Molecular Hepatology |
| Fag: | |
| Online adgang: | http://e-cmh.org/upload/pdf/cmh-2025-0888.pdf |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
